Company: Bioverge Inc.
Founder(s): Neil Littman
Business: Online venture capital firm specialising in investing in early-stage healthcare start ups.
Bioverge, founded in 2016, is an equity crowdfunding investment platform that funds visionary entrepreneurs with the aim of transforming healthcare and bringing science fiction to life by accelerating the development of solutions for intractable problems in healthcare.
Bioverge has completed 30 investments to date via its syndication model and has invested in companies supported by some of the world’s top-performing VCs including Andreesen Horowitz, Thiel Capital, NEA, First Round Capital., and Y Combinator to name a few.
Bioverge aims to “disrupt to differentiate” by building a team of healthcare specific resources far more valuable than any standalone investor or the transactional nature of platform competitors. The Bioverge Network is comprised of functional specialists capable of supporting scientific and technical founders alongside experts to source and conduct diligence on new investment opportunities.
For portfolio companies, the Network offers value-added support by discerning companies’ specific needs, providing guidance, and leveraging the Bioverge Network to connect them with strategic partners, advisors, subject matter experts, sources of non-dilutive funding, and traditional venture capital firms and institutional investors.